Fludeoxyglucose F 18 positron emission tomography/computed tomography (PET/CT) has been invaluable in the assessment of melanoma throughout the course of the disease. As with any modality, the studies are incomplete and more information will be gleaned as our experience progresses. Additionally, it is hoped that a newer PET agent in the pipeline will give us even greater success in the identification and subsequent treatment of melanoma. This article aims to examine the utilization of PET/CT in the staging, prognostication, and follow-up of melanoma while providing the physicians who order and interpret these studies practical guidelines and interpretive pitfalls.
机构:
Hosp La Princesa, IIS Princesa, Dept Rheumatol, C Diego Leon 62, Madrid 28006, Spain
Univ Autonoma Madrid, Dept Med, Catedra UAM ROCHE, EPID Future, Madrid, SpainHosp La Princesa, IIS Princesa, Dept Rheumatol, C Diego Leon 62, Madrid 28006, Spain
Castaneda, Santos
Vicente, Esther F.
论文数: 0引用数: 0
h-index: 0
机构:
Hosp La Princesa, IIS Princesa, Dept Rheumatol, C Diego Leon 62, Madrid 28006, SpainHosp La Princesa, IIS Princesa, Dept Rheumatol, C Diego Leon 62, Madrid 28006, Spain
Vicente, Esther F.
Gonzalez-Gay, Miguel A.
论文数: 0引用数: 0
h-index: 0
机构:
Hosp Univ Marques Valdecilla, IDIVAL, Dept Rheumatol, Santander, Spain
Univ Cantabria, Dept Med, Santander, Cantabria, SpainHosp La Princesa, IIS Princesa, Dept Rheumatol, C Diego Leon 62, Madrid 28006, Spain